Preventing hepatitis B reactivation in HBsAg-positive patients with untreated diffuse large B-cell lymphoma with R-CHOP chemotherapy: A prospective study to compare entecavir and lamivudine
机构:[1]Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China中山大学肿瘤防治中心[2]Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China临床科室内科中山大学肿瘤防治中心
出处:
ISSN:
语种:
外文
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2013]版:
大类|1 区医学
小类|1 区肿瘤学
最新[2023]版:
大类|1 区医学
小类|1 区肿瘤学
第一作者:
第一作者机构:[1]Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China[2]Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
推荐引用方式(GB/T 7714):
Huang He,Li Xue Ying,Li Hao Ran,et al.Preventing hepatitis B reactivation in HBsAg-positive patients with untreated diffuse large B-cell lymphoma with R-CHOP chemotherapy: A prospective study to compare entecavir and lamivudine[J].JOURNAL OF CLINICAL ONCOLOGY.2013,31(15):-.
APA:
Huang, He,Li, Xue Ying,Li, Hao Ran,Shrestha, Prem Raj,Guo, Cheng-cheng...&Lin, Tongyu.(2013).Preventing hepatitis B reactivation in HBsAg-positive patients with untreated diffuse large B-cell lymphoma with R-CHOP chemotherapy: A prospective study to compare entecavir and lamivudine.JOURNAL OF CLINICAL ONCOLOGY,31,(15)
MLA:
Huang, He,et al."Preventing hepatitis B reactivation in HBsAg-positive patients with untreated diffuse large B-cell lymphoma with R-CHOP chemotherapy: A prospective study to compare entecavir and lamivudine".JOURNAL OF CLINICAL ONCOLOGY 31..15(2013):-